Covidien, LP recalls Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX

Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.

The firm began notifying consignees on 7/7/26 via email, mail, or electronically. Notices were titled, "URGENT: VOLUNTARY MEDICAL DEVICE RECALL." Customers were informed of the manufacturing nonconformance. If products in scope of this field action have been used in patients under the customer's care, the customer is instructed to monitor for signs of infection or vision issues due to the possibility of biocontamination. Customers were instructed to immediately identify, cease use, and quarantine all unused impacted product. Unused impacted product is to be returned to Medtronic. The recall notice should be passed on to all those who need to be aware within the customer's organization or to any organization where devices have been transferred.

• FDA enforcement recordOfficial FDA database entry for Z-2922-2026
• FDA 510(k) clearance · K050947The device's official FDA premarket clearance record
• FDA device classification · GAWOfficial FDA classification for this device type
• CFR regulation · 21 CFR 878.5010The federal regulation governing this device
• FDA recall announcementSearch FDA.gov for the official press announcement
• Find Covidien, LPSearch for the manufacturer's official notice
• News coverageRecent reporting on this recall and manufacturer
• openFDA data recordThe raw JSON record this page is built from

Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.